Apr 30
Shaping the future of asthma care

Shaping the future of asthma management with the NObreath® at ATS 2026

Bedfont® Scientific Limited to showcase why the NObreath® is the FeNO device of choice at this year’s global event. World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO)... read more →
Apr 21
Advancements in FeNO testing

Advancements in FeNO testing for better asthma control

In 2019, 262 million people worldwide had asthma, with 455,000 deaths from the chronic condition1, stark figures that highlight asthma control still needs improvement. Most people living with asthma believe that no physical symptoms mean their asthma is controlled, but this is sadly not always the case. Airway inflammation is... read more →
Apr 08
Mar 11
Feb 03
FeNO Testing in Asthma Management

The Role of FeNO Testing in Asthma Management

Asthma is a chronic lung condition that causes airway inflammation and affects approximately 262 million people worldwide1. Typical symptoms include: Wheezing, Breathlessness, Chest tightness, Coughing. When airways are inflamed, breathing can become difficult. Recent Asthma + Lung UK research found that over 42,000 people ended up in emergency care in... read more →
Jan 21
Jan 13

coVita™ and Allergy Partners team up to improve asthma care in America

Innovative NObreath® FeNO device is the allergists' device of choice in the USA. coVita™ LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath® Fractional Exhaled Nitric Oxide (FeNO) device from UK-based Bedfont® Scientific Ltd. The new agreement with Allergy Partners... read more →
Jan 06
Nov 27

Bedfont® Scientific Limited Expands Global Access to FeNO Testing in India

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region. Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices, has collaborated with Rbeck Healtech Private to make Fractional exhaled... read more →
Nov 27